Open AccessTYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma
Author(s) -
Wu Ping,
Xiang Tingting,
Wang Jing,
Lv Run,
Wu Guangzhen
Publication year - 2020
Publication title -
febs open bio
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.718
H-Index - 31
ISSN - 2211-5463
DOI - 10.1002/2211-5463.12993
Subject(s) - clear cell renal cell carcinoma , kegg , gene , biology , cancer research , cd8 , biomarker , genome , cell , immunotherapy , renal cell carcinoma , immune system , transcriptome , computational biology , oncology , gene expression , immunology , medicine , genetics
Clear cell renal cell carcinoma (ccRCC) exhibits high recurrence and metastasis rates. Although targeted therapy has significantly improved the prognosis of some patients with ccRCC, the median survival rate remains poor. In this article, we used a series of bioinformatics analyses to identify TYROBP as a potential target for diagnosis and treatment of ccRCC.